Welby Inc.
Stock Price Chart
2026/10/09 19:27 UpdatedPrice Trend
2026/10/09 19:27 UpdatedPrice & Trading Details
2026/10/09 19:27 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/10/01Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥1,051M | ¥575M | ¥528M | ¥636M |
| Gross Profit | ¥755M | ¥376M | ¥380M | ¥449M |
| Operating Income | ¥61M | -¥437M | -¥654M | -¥453M |
| Pretax Income | ¥38M | -¥503M | -¥815M | -¥530M |
| Net Income | ¥34M | -¥505M | -¥805M | -¥540M |
| EPS | ¥4.33 | -¥64.51 | -¥98.61 | -¥65.21 |
| Operating Margin | 5.80% | -75.99% | -123.94% | -71.23% |
| Balance Sheet | ||||
| Total Assets | ¥1,396M | ¥1,205M | ¥1,167M | ¥1,054M |
| Total Equity | ¥1,274M | ¥1,091M | ¥810M | ¥272M |
| Total Liabilities | ¥121M | ¥115M | ¥357M | ¥782M |
| Cash | ¥831M | ¥883M | ¥740M | ¥711M |
| Interest-bearing Debt | ¥8M | ¥1M | ¥200M | ¥606M |
| Equity Ratio | 91.30% | 90.48% | 69.40% | 25.83% |
| D/E Ratio | 0.01 | 0.00 | 0.25 | 2.22 |
| Cash Flow | ||||
| Operating CF | -¥114M | -¥174M | -¥604M | -¥329M |
| Investing CF | -¥7M | -¥114M | -¥236M | -¥106M |
| Financing CF | -¥9M | ¥341M | ¥697M | ¥406M |
| Free CF | -¥147M | -¥259M | -¥776M | -¥431M |
| Efficiency | ||||
| ROE | 2.66% | -46.33% | -99.33% | -198.18% |
| ROA | 2.43% | -41.92% | -68.93% | -51.19% |
Latest IR Information
-
Notice Regarding the Issuance of New Shares through Third-Party Allotment
Through a third-party allotment, 100,000 ordinary shares will be allocated to Mr. Takashi Hikiyuki, with funds raised of 50,000,000 yen. The proceeds will be used for development investments in the PHR platform business, with a payment deadline of September 30,...
Read more -
Q2 FY2026 Results Briefing Materials (Matters on Business Plan and Growth Prospects)
Read more -
Interim Financial Results for the Second Quarter of the Fiscal Year Ending December 2026 [Japan GAAP] (Consolidated)
Read more -
Financial Results for the Second Quarter (Mid-Year) of Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)
Read more
Latest News (5 items)
Company Information
About
Welby Inc. engages in the provision of digital health solutions that help patients to get medical care services in Japan. The company provides services in the areas of diabetes, lifestyle-related disease, autoimmune disease, rare disease, oncology, and blood disorders. It also engages in the medical data research business; and operates apps, web services, and data management. Welby Inc. was incorporated in 2011 and is headquartered in Chuo, Japan.
